The Role of Ai in the Spread of False Information during High-Profile Trials

Abstract

In recent years, the rapid advancements in artificial intelligence (AI) technologies have raised concerns about their role in the spread of false information, particularly in high-profile legal cases. In India, where the judicial system has seen increasing media coverage and public scrutiny of trials, AI-driven misinformation poses significant risks to the integrity of legal proceedings. The spread of misleading or entirely fabricated content, such as deepfakes, AI-generated news, and manipulated social media posts, has the potential to influence public opinion, jury impartiality, and even the decisions of legal professionals involved in the case.

This paper explores the role of AI in the dissemination of false information during high-profile trials in India. It examines how AI tools, including automated content generation and deep learning algorithms, have been used to create and spread misleading narratives surrounding court cases. These narratives often distort facts, misrepresent evidence, or introduce fabricated claims that can shape public perceptions, potentially prejudicing legal outcomes. The paper further delves into the specific challenges faced by the Indian legal system in addressing the proliferation of AI-generated misinformation, particularly in the context of ongoing trials that attract widespread media attention.

Moreover, the paper discusses the legal and ethical implications of AI-generated misinformation, including the difficulties in regulating the technology and ensuring the accuracy of information presented in court. It proposes potential strategies to combat the spread of false information, such as improved media literacy, stricter regulation of AI-generated content, and the integration of AI tools in verifying the authenticity of media during legal proceedings. Finally, the paper underscores the need for collaboration between legal experts, technology developers, and policymakers to safeguard the fairness and integrity of high-profile trials in India.